United States · FDA National Drug Code directory

Prazosin Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 70954-020_8420b1bd-9aba-43e5-96e1-15ef2342cd12
Product NDC: 70954-020
Form: CAPSULE
Composition / generic term: Prazosin Hydrochloride
Labeler: ANI Pharmaceuticals, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20181003
Source listing expiry: 20271231

Source-listed ingredients

PRAZOSIN HYDROCHLORIDE — 2 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 CAPSULE in 1 BOTTLE (70954-020-10) · 70954-020-10
1000 CAPSULE in 1 BOTTLE (70954-020-20) · 70954-020-20
100 BLISTER PACK in 1 CARTON (70954-020-40) / 1 CAPSULE in 1 BLISTER PACK (70954-020-30) · 70954-020-40

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →